4 Biotech Startups Developing Breakthrough Drug Modalities
In the dynamic world of drug discovery, companies must continually innovate beyond their existing drug portfolios and modalities. Relying solely …
Biopharma Insights
The Growing Impact of AI in Healthcare
The advent of artificial intelligence (AI) in healthcare has catalyzed an epoch of change, reshaping diagnostic procedures, therapeutic strategies, and …
Is AI impacting the Life Sciences real estate market?
Artificial intelligence (AI) is one of the most disruptive technologies the Life Sciences sector has ever seen. It’s having a …
From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development
Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US …
Optimising Drug Discovery R&D with Graphs
Data in Life Sciences expert Dr Alexander Jarasch on a new wave of advanced data handling techniques that point the …
A Landscape of AI-discovered Molecules and Target Novelty Analysis
We have recently launched a report, “It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?” where …
How Industry Embraces Organ-on-Chips: A 2024 Status Report
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …
11 Notable Companies Enabling Decentralized Clinical Trials
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
How AI Empowers Biomarker-Driven Clinical Trials
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert
In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of …
It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?
The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning …
These 22 Biotechs Collectively Raised $3.3 Billion in Q1 2024. What Do They Have to Offer?
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021. …